- Market cap
- Revenue
- Net income
- Cash on hand
- Gross margin
- Net margin
- EPS
- P/E ratio
In 1996, Fresenius SE & Co. KGaA merged its dialysis business into W.R. Grace 's National Medical Care to form Fresenius Medical Care.
In 2000, the company pleaded guilty to billing Medicare for unnecessary medical tests and to paying kickbacks for lab business and paid a $486 million fine.
In February 2012, the company acquired Liberty Dialysis Holding, which added 201 clinics, for $1.5 billion.
In March 2012, Rice Powell was appointed CEO.
In 2013, the company acquired Shiel Medical Laboratory, expanding services to New York City metro area. In December 2017, the company sold this business to Quest Diagnostics.
In February 2019, the company acquired NxStage, a U.S.-based maker of in-home dialysis devices, for $2 billion.